Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide

Cancer Investigation

Volumn 25, Issue 4, 2007, Pages 249-255

  Schwarzberg, Abraham B ^a,b   Stover, Elizabeth H ^b   Sengupta, Tanya ^b   Michelini, Ann ^b   Vincitore, Michele ^b   Baden, Lindsey R ^a,c   Kulke, Matthew H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Carcinoid; Lymphopenia; Neuroendocrine tumor; Opportunistic infection; Pneumocystis jiroveci pneumonia; Temozolomide

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT; DEXAMETHASONE; DOXORUBICIN; OCTREOTIDE; STREPTOZOCIN; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG WITHDRAWAL; FEMALE; HERPES ZOSTER; HUMAN; INCIDENCE; LEUKOPENIA; LOW DRUG DOSE; LYMPHOCYTOPENIA; MALE; MONITORING; NAUSEA; NEUROENDOCRINE TUMOR; NEUTROPENIA; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TREATMENT WITHDRAWAL; VARICELLA ZOSTER VIRUS;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CYTOMEGALOVIRUS INFECTIONS; DACARBAZINE; FEMALE; HERPES ZOSTER; HUMANS; INCIDENCE; LYMPHOPENIA; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS;

EID: 34347405488     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701206380     Document Type: Article

References (30)

1. Middleton, M.R.; Grob, J.J.; Aaronson, N.; Fierlbeck, G.; Tilgen, W.; et al. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J. Clin. Oncol. 2000, 18 (1), 158-166.
2. Korones, D.N.; Benita-Weiss, M.; Coyle, T.E.; Mechtler, L.; Bushunow, P.; et al. Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant glioma. Cancer 2003, 97 (8), 1963-1968.
3. Su, Y.B.; Sohn, S.; Krown, S.E.; Livingston, P.O.; Wolchok, J.D.; et al. Selective CD4 + lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J. Clin. Oncol. 2004, 22 (4), 610-616.
4. Kulke, M.H.; Ryan, D.P.; Stuart, K.; Morgan, J.A.; Clark, J.W.; et al. Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors. J. Clin. Oncol. 2006, 24 (3), 401-406.
5. Brock, C.S.; Newlands, E.S.; Wedge, S.R.; Bower, M.; Evans, H.; et al. Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res. 1998, 58 (19), 4363-4367.
6. Poplin, E.A.; Gordon, C.J.; Piskorowski, T.J.Chandrasekar, P.H. Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndrome. Cancer 1991, 68 (1), 193-194.
7. Kulke, M.H.; Vance, E.A. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin. Infect. Dis. 1997, 25 (2), 215-218.
8. Sepkowitz, K.A. Pneumocystis carinii pneumonia among patients with neoplastic disease. Semin. Respir. Infect. 1992, 7 (2), 114-121.
9. Sepkowitz, K.A.; Brown, A.E.; Telzak, E.E.; Gottlieb, S.; Armstrong, D. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992, 267 (6), 832-837.
10. Zahar, J.R.; Robin, M.; Azoulay, E.; Fieux, F.; Nitenberg, G.; Schlemmer, B. Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study. Clin. Infect. Dis. 2002, 35 (8), 929-934.
11. Gnann, J.W., Jr.; Whitley, R.J. Clinical practice. Herpes zoster. N. Engl. J. Med. 2002, 347 (5), 340-346.
12. Gnann, J.W., Jr. Varicella-zoster virus: atypical presentations and unusual complications. J. Infect. Dis. 2002, 186 (Suppl. 1), S91-S98.
13. Locksley, R.M.; Flournoy, N.; Sullivan, K.M.; Meyers, J.D. Infection with varicella-zoster virus after marrow transplantation. J. Infect. Dis. 1985, 152 (6), 1172-1181.
14. Landolfo, S.; Gariglio, M.; Gribaudo, G.; Lembo, D. The human cytomegalovirus. Pharmacol. Ther. 2003, 98 (3), 269-297.
15. Matthes, T.; Kaiser, L.; Weber, D.; Kurt, A.M.; Dietrich, P.Y. Cytomegalovirus colitis - a severe complication after standard chemotherapy. Acta Oncol. 2002, 41 (7-8), 704-706.
16. Sepkowitz, K.A. Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome. Clin. Infect. Dis. 2002, 34 (8), 1098-1107.
17. Chang, S.M.; Prados, M.D.; Yung, W.K.; Fine, H.; Junck, L.; Greenberg, H.; et al. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer 2004, 100 (8), 1712-1716.
18. Stupp, R.; Dietrich, P.Y.; Ostermann Kraljevic, S.; Pica, A.; Maillard, I.; et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J. Clin. Oncol. 2002, 20 (5), 1375-1382.
19. Hwu, W.J.; Krown, S.E.; Menell, J.H.; Panageas, K.S.; Merrell, J.; et al. Phase II study of temozolomide plus thalidomide for the treatment of metastatic melanoma. J. Clin. Oncol. 2003, 21 (17), 3351-3356.
20. Fulkerson, W.J.; Newman, J.H. Endogenous Cushing's syndrome complicated by Pneumocystis carinii pneumonia. Am. Rev. Respir. Dis. 1984, 129 (1), 188-189.
21. Kim, D.S.; Park, S.K.; Choi, W.H.; Kim, T.W.; Choi, Y.Y.; et al. Pneumocystis carinii pneumonia associated with a rapid reduction of cortisol level in a patient with ectopic ACTH syndrome treated by octreotide and ketoconazole. Exp. Clin. Endocrinol. Diabetes 2000, 108 (2), 146-150.
22. Natale, R.B.; Yagoda, A.; Brown, A.; Singer, C.; Stover, D. Bajorunas, D.; Combined Pneumocystis carinii and Nocardia asteroides pneumonitis in a patient with an ACTH-producing carcinoid. Cancer 1981, 47 (12), 2933-2935.
23. Arend, S.M.; Kroon, F.P.; van't Wout, J.W. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. an analysis of 78 cases. Arch. Intern. Med. 1995, 155 (22), 2436-2441.
24. Russian, D.A.; Levine, S.J. Pneumocystis carinii pneumonia in patients without HIV infection. Am. J. Med. Sci. 2001, 321 (1), 56-65.
25. Varthalitis, I.; Aoun, M.; Daneau, D.; Meunier, F. Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer 1993, 71 (2), 481-485.
26. Mansharamani, N.G.; Garland, R.; Delaney, D.; Koziel, H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 2000, 118 (3), 704-711.
27. Kovacs, J.A.; Masur, H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N. Engl. J. Med. 2000, 342 (19), 1416-1429.
28. Einsele, H.; Ehninger, G.; Hebart, H.; Wittkowski, K. M.; Schuler, U.; et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995, 86 (7), 2815-2820.
29. Peggs, K.S.; Preiser, W.; Kottaridis, P.D.; McKeag, N.; Brink, N.S.; et al. Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation. Br. J. Haematol. 2000, 111 (3), 782-790.
30. Mansharamani, N.G.; Balachandran, D.; Vernovsky, I.; Garland, R.; Koziel, H. Peripheral blood CD4 + T-lymphocyte counts during Pneumocystis carinii pneumonia in immunocompromised patients without HIV infection. Chest 2000, 118 (3), 712-720.